These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 12548104)

  • 1. Hormone replacement therapy and cancer: an update.
    La Vecchia C; Franceschi S
    Eur J Cancer Prev; 2003 Feb; 12(1):3-4. PubMed ID: 12548104
    [No Abstract]   [Full Text] [Related]  

  • 2. Making decisions about hormone replacement therapy.
    Rymer J; Wilson R; Ballard K
    BMJ; 2003 Feb; 326(7384):322-6. PubMed ID: 12574048
    [No Abstract]   [Full Text] [Related]  

  • 3. Menopause, hormone replacement therapy and cancer.
    La Vecchia C; Brinton LA; McTiernan A
    Maturitas; 2001 Aug; 39(2):97-115. PubMed ID: 11514109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormone replacement therapy after cancers.
    Creasman WT
    Curr Opin Oncol; 2005 Sep; 17(5):493-9. PubMed ID: 16093802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exogenous steroids for menopausal symptoms and breast/endometrial cancer risk.
    Mourits MJ; DE Bock GH
    Int J Gynecol Cancer; 2006; 16 Suppl 2():494-6. PubMed ID: 17010054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hormone replacement therapy in menopause: continue or stop the prescription after 10 years? There are reasons to continue hormone replacement therapy longer than 10 years].
    Rozenbaum H
    Gynecol Obstet Fertil; 2002 Sep; 30(9):723-32. PubMed ID: 12448371
    [No Abstract]   [Full Text] [Related]  

  • 7. Hormone replacement therapy and malignancy.
    Fitzgerald CT; Elstein M; Mansel RE
    Br J Obstet Gynaecol; 1993 May; 100(5):408-10. PubMed ID: 8518237
    [No Abstract]   [Full Text] [Related]  

  • 8. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
    Genazzani AR; Gadducci A; Gambacciani M
    Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risks and benefits of hormone replacement therapy.
    de Lignières B; MacGregor EA
    Cephalalgia; 2000 Apr; 20(3):164-9. PubMed ID: 10997769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormone replacement therapy and cancer.
    Gynecol Endocrinol; 2001 Dec; 15(6):453-65. PubMed ID: 11826770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancers in Australia in 2010 attributable to and prevented by the use of menopausal hormone therapy.
    Jordan SJ; Wilson LF; Nagle CM; Green AC; Olsen CM; Bain CJ; Pandeya N; Whiteman DC; Webb PM
    Aust N Z J Public Health; 2015 Oct; 39(5):434-40. PubMed ID: 26437728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormone replacement and cancer.
    Barrett-Connor E
    Br Med Bull; 1992 Apr; 48(2):345-55. PubMed ID: 1450874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hormone replacement therapy and the risk of developing breast cancer].
    Merz WE
    MMW Fortschr Med; 2004 Feb; 146(9):26-8, 30. PubMed ID: 15352702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tibolone: cancers of the breast and endometrium.
    Prescrire Int; 2006 Jun; 15(83):107. PubMed ID: 16764100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormone replacement therapy and female malignancy: what has the Million Women Study added to our knowledge?
    Marsden J
    J Fam Plann Reprod Health Care; 2007 Oct; 33(4):237-43. PubMed ID: 17925102
    [No Abstract]   [Full Text] [Related]  

  • 16. Hormone replacement therapy and cancer.
    Mack TM
    Baillieres Clin Endocrinol Metab; 1993 Jan; 7(1):113-49. PubMed ID: 8435049
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hormone therapy in climacteric. Different effects of estrogen and gestagen on the risk of breast and endometrial cancer].
    Magnusson C; Weiderpass E
    Lakartidningen; 2001 Jan; 98(5):418-21. PubMed ID: 11229082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Use of oral contraceptives and risk of cancer, a cohort study].
    Kumle M; Alsaker E; Lund E
    Tidsskr Nor Laegeforen; 2003 Jun; 123(12):1653-6. PubMed ID: 12821980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Postmenopausal hormone replacement therapy--is there a cause of worry?].
    Skouby SO; Wilken-Jensen C; Jespersen J; Pedersen AT; Ottesen BS
    Ugeskr Laeger; 2002 Aug; 164(34):3974-5. PubMed ID: 12212482
    [No Abstract]   [Full Text] [Related]  

  • 20. Postmenopausal hormone replacement therapy for primary prevention of chronic conditions: recommendations and rationale.
    U.S. Preventive Services Task Force
    Ann Intern Med; 2002 Nov; 137(10):834-9. PubMed ID: 12435221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.